On behalf of its members, ACTA will have a role in:
- promoting the advantages and benefits of investigator-initiated clinical trials and clinical quality registries;
- raising awareness of the need for, and valuable contributions of, clinical trials networks, trial coordinating centres and clinical quality registries within the healthcare system;
- bringing focus to common issues impacting the conduct of clinical trials and clinical quality registries;
- facilitating collaboration among clinical trials networks, trial coordinating centres and clinical quality registries;
- coordinating communication and consultation with clinician researchers;
- providing expert advice on investigator-initiated clinical trials and clinical quality registries to Governments, policymakers and others;
- developing policy recommendations for improving the quality and impact of investigator-initiated clinical trials and clinical quality registries;
- supporting the development of new clinical trials networks and clinical quality registries that conduct, or support the conduct of investigator-initiated clinical trials;
- encouraging capacity building for the clinical research workforce;
- promoting education and training opportunities for clinical researchers;
- coordinating projects, with the aim of improving all aspects of clinical trials and registries including efficiency;
- fostering effective partnerships between clinician researchers and Governments, policy-makers, health care providers, industry and consumers.